Literature DB >> 31943313

Review of therapeutic drug monitoring of infliximab in spondyloarthritis-Catching up with management concepts from other inflammatory conditions.

Nikola Mitrev1, Viraj Kariyawasam1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31943313      PMCID： PMC7015740          DOI： 10.1111/bcp.14129

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.

Authors:  Henit Yanai; Lev Lichtenstein; Amit Assa; Yoav Mazor; Batia Weiss; Arie Levine; Yulia Ron; Uri Kopylov; Yoram Bujanover; Yoram Rosenbach; Bella Ungar; Rami Eliakim; Yehuda Chowers; Raanan Shamir; Gerald Fraser; Iris Dotan; Shomron Ben-Horin
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-25       Impact factor: 11.382

2.  Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn's disease.

Authors:  A J Yarur; V Kanagala; D J Stein; F Czul; M A Quintero; D Agrawal; A Patel; K Best; C Fox; K Idstein; M T Abreu
Journal:  Aliment Pharmacol Ther       Date:  2017-02-17       Impact factor: 8.171

3.  Review of therapeutic drug monitoring of infliximab in spondyloarthritis-Catching up with management concepts from other inflammatory conditions.

Authors:  Nikola Mitrev; Viraj Kariyawasam
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

4.  Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.

Authors:  Bella Ungar; Idan Levy; Yarden Yavne; Miri Yavzori; Orit Picard; Ella Fudim; Ronen Loebstein; Yehuda Chowers; Rami Eliakim; Uri Kopylov; Shomron Ben-Horin
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-29       Impact factor: 11.382

Review 5.  Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Authors:  N Mitrev; N Vande Casteele; C H Seow; J M Andrews; S J Connor; G T Moore; M Barclay; J Begun; R Bryant; W Chan; C Corte; S Ghaly; D A Lemberg; V Kariyawasam; P Lewindon; J Martin; R Mountifield; G Radford-Smith; P Slobodian; M Sparrow; C Toong; D van Langenberg; M G Ward; R W Leong
Journal:  Aliment Pharmacol Ther       Date:  2017-10-13       Impact factor: 8.171
  5 in total
  1 in total

1.  Review of therapeutic drug monitoring of infliximab in spondyloarthritis-Catching up with management concepts from other inflammatory conditions.

Authors:  Nikola Mitrev; Viraj Kariyawasam
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.